NantOmics Overview

  • Founded

  • 2012

Founded
  • Status

  • Private

  • Employees

  • 14

Employees
  • Latest Deal Type

  • Early Stage VC

  • Latest Deal Amount

  • $251M

  • Investors

  • 2

NantOmics General Information

Description

Provider of molecular diagnostic testing services intended to detect genomic and proteomic alterations in cancer and identify potential treatment options for the personalized management of patients. The company's molecular diagnostics approach combines DNA sequencing, RNA sequencing, and quantitative proteomics to unearth the genomic and proteomic variances that initiate and drive cancer, by analyzing both normal and tumor cells, enabling cancer patients to access personalized points of care.

Contact Information

Website
www.nantomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 9920 Jefferson Street
  • Culver City, CA 90232
  • United States
+1 (301) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NantOmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 18-Sep-2015 $251M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 15-Jan-2015 0000 0000 Completed Generating Revenue
To view NantOmics’s complete valuation and funding history, request access »

NantOmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of molecular diagnostic testing services intended to detect genomic and proteomic alterations in cancer and ide
Biotechnology
Culver City, CA
14 As of 2021
00000
0000000000 0 00000

00000

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000000000000
Aliso Viejo, CA
000 As of 0000
00 0000-00-00
000000&0

000000

e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
000000000 00000 (0000000000)
Baltimore, MD
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NantOmics Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambry Genetics Private Equity-Backed Aliso Viejo, CA 000 000000&0
00000000 000000 00 Formerly VC-backed Baltimore, MD 000 00000 000000&0 00000
00000000 Formerly VC-backed Boulder, CO 000 00000 000000000 00000
00000 0000 0000000 Private Equity-Backed Irving, TX 0000 00.00 0000000 0000 00.00
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
You’re viewing 5 of 8 competitors. Get the full list »

NantOmics Patents

  • 353

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 27

    Granted

  • 27

    Pending

  • 000

    Expiring in next 12 mo

NantOmics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220170099-A1 Immunome profiling for engineering white blood cells Pending 25-Jul-2019 0000000000
DE-112020001314-T5 System and procedure for data curation Pending 18-Mar-2019 000000000 0
US-20200303033-A1 System and method for data curation Pending 18-Mar-2019 0000000000
US-20220108768-A1 System and method for variant calling Pending 08-Mar-2019 000000000
EP-3935638-A1 System and method for variant calling Pending 08-Mar-2019 G16B20/20
To view NantOmics’s complete patent history, request access »

NantOmics Executive Team (3)

Name Title Board Seat Contact Info
Shahrooz Rabizadeh Ph.D Chief Scientific Officer
Patrick Soon-Shiong MD Founder, Chief Executive Officer & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

NantOmics Board Members (1)

Name Representing Role Since
Patrick Soon-Shiong MD Self Founder, Chief Executive Officer & Board Member 000 0000
To view NantOmics’s complete board members history, request access »

NantOmics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NantOmics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Capital Equity PE/Buyout Minority 000 0000 000000 0
Relay Ventures Venture Capital Minority 000 0000 000000 0
To view NantOmics’s complete investors history, request access »

NantOmics Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 13-Apr-2017 0000000000 Biotechnology 0000000 0
00000 0000000 02-Nov-2016 000000000 000 Biotechnology 0000000 0
000000000 18-Oct-2016 00000 0000 00.000 Decision/Risk Analysis
00000000 0000 10-Sep-2015 0000000000 Diagnostic Equipment 0000000 0
OncoPlex Diagnostics 01-Jan-2008 Later Stage VC 0000 Diagnostic Equipment 0000000 0
To view NantOmics’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial